An overview of macrolide resistance in streptococci: prevalence, mobile elements and dynamics
D Berbel, A González-Díaz, G López de Egea… - Microorganisms, 2022 - mdpi.com
Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of
allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the …
allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the …
[HTML][HTML] Prevalence of Group B Streptococcus maternal colonization, serotype distribution, and antimicrobial resistance in Sub-Saharan Africa: A systematic review …
F Wadilo, E Hailemeskel, K Kedir, Z El-Khatib… - Journal of Global …, 2023 - Elsevier
ABSTRACT Objective Group B Streptococcus (GBS)-associated maternal, perinatal, and
neonatal mortality and morbidity disproportionately affects Sub-Saharan Africa (SSA). This …
neonatal mortality and morbidity disproportionately affects Sub-Saharan Africa (SSA). This …
Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China
Z Liu, X Jiang, J Li, W Ji, H Zhou, X Gong… - Frontiers in …, 2023 - frontiersin.org
Streptococcus agalactiae (Group B Streptococcus, GBS) is a major cause of neonatal
infections with high morbidity and mortality, and clindamycin is the main antibiotic used to …
infections with high morbidity and mortality, and clindamycin is the main antibiotic used to …
Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility of Streptococcus agalactiae Isolated from Young Infants
Z Jin, J Li, H Zhou, Z Wang, L Yi, N Liu, J Du… - Pathogens, 2022 - mdpi.com
Background: Streptococcus agalactiae (Group B Streptococcus, GBS) is the most common
cause of serious infections in the first 3 months of life worldwide. The pathogenicity of GBS is …
cause of serious infections in the first 3 months of life worldwide. The pathogenicity of GBS is …
Antibacterial Efficacy of Morinda lucida and Vernonia amygdalina Leaf Extracts against Antibiotic Resistant Salmonella species
MB Mshelia, DA Zenoh, IV Fasogbon… - African Journal of …, 2024 - ojshostng.com
The emergence and reemergence antibacterial resistance has made it more difficult for a
choice of effective antibiotics to treat infections caused by bacteria. Antimicrobial resistant …
choice of effective antibiotics to treat infections caused by bacteria. Antimicrobial resistant …
Treatment and prevention of neonatal sepsis
AU Bjerkhaug - 2024 - munin.uit.no
Worldwide, the incidence of neonatal sepsis is estimated at around 3000 cases per 100,000
live births, accompanied by a mortality rate of 17.6%. Group B streptococcus (GBS) is …
live births, accompanied by a mortality rate of 17.6%. Group B streptococcus (GBS) is …
DETEKCIJA REZISTENCIJE NA ANTIBIOTIKE I KAPSULARNIH TIPOVA STREPTOKOKA GRUPE B IZOLOVANIH KOD KOLONIZOVANIH TRUDNICA
B Paunović, D Kekić, J Kabić, I Gajić… - Medicinski …, 2023 - aseestant.ceon.rs
Sažetak Uvod: Streptokok grupe B (GBS) predstavlja oportunističkog patogena koji
kolonizuje gastrointestinalni i genitalni trakt 10-30% zdravih ljudi. GBS može prouzrokovati …
kolonizuje gastrointestinalni i genitalni trakt 10-30% zdravih ljudi. GBS može prouzrokovati …
[HTML][HTML] Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a …
AM AL-HAMAD, MA Mohammed, M ALSHEIKH… - Group, 2023 - mjima.org
Summary Introduction: Group B streptococcus (GBS) is recognized as a significant cause of
neonatal infections worldwide. The study investigated the burden of early-onset neonatal …
neonatal infections worldwide. The study investigated the burden of early-onset neonatal …